Knowledge and practices of using antibiotics by patients with acute respiratory infections
pdf

Keywords

antibiotics
antibiotics in acute respiratory infections
antibiotics in primary healthcare
self-medication
antibiotic resistance

How to Cite

COTELEA, V. (2023) “Knowledge and practices of using antibiotics by patients with acute respiratory infections”, One Health & Risk Management , 5(1), pp. 27-33. doi: 10.38045/ohrm.2024.1.04.

Abstract

Introduction. Excessive and inappropriate antibiotic (AB) consumption is associated with the development of antibiotic resistance (AR). Insufficient knowledge and irrational practices in the use of AB for acute respiratory infections (ARI) by patients contribute to the development of AR. Aim: to assess the knowledge and practices of AB use in patients with ARI in order to identify educational needs.

Material and methods. The study included 393 patients with ARI. The standardized Happy Audit-2 questionnaire was applied. Complaints, the frequency of ARI occurrence, administered AB treatment, AB acquisition method, AB compliance, knowledge about AB, and AB resistance were assessed.

Results. AB were used by 40.3% of the patients. Antibiotic treatment was recommended by a doctor in 87.6% of cases, taken independently by 5.6%, recommended by a pharmacist in 5.0%, and recommended by relatives in 1.9% of cases. AB were obtained without a prescription in 6.3% of cases, and household reserves were used in 20.8% of cases. Patients were compliant with antibiotic treatment in 89.7% of cases but 10.3% of respondents did not adhere to the prescribed duration/dosage. 26.7% of respondents believed that AB were effective against viral infections, and 13.8% believed they were harmless to the human body. In 24.1% of cases, respondents were unaware of the adverse effects of AB, including the development of bacterial resistance in 29.7% of cases.

Conclusions. Insufficient knowledge about the effects of antibiotics and irrational usage practices, including self-medication, emphasize the need for strengthening awareness and education measures for potential antibiotic users.

https://doi.org/10.38045/ohrm.2024.1.04
pdf

|Views: 223| |pdf Downloads: 187|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Valeria Cotelea

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370